Showing results (91-100 of 600) with videos related to
Sort By:
Pageof 60
British Journal of Pharmacology|January 1, 1973
Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleenS H Ferreira, S Moncada, J R VaneActa Biologica Et Medica Germanica|January 1, 1978
Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculationB J Whittle, S Moncada, J R VaneEuropean Journal of Pharmacology|October 1, 1977
Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pigG J Dusting, S Moncada, J R VaneProstaglandins|August 1, 1978
Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat pawE A Higgs, S Moncada, J R VaneProstaglandins|September 1, 1978
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesB J Whittle, S Moncada, J R VaneBritish Journal of Pharmacology|June 1, 1989
Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusionC Thiemermann, G R Thomas, J R VaneBritish Journal of Pharmacology|November 1, 1990
Sodium nitroprusside modulates the fibrinolytic system in the rabbitP S Lidbury, R Korbut, J R VaneProceedings of the National Academy of Sciences of the United States of America|September 15, 1992
Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbitsR S Sprague, C Thiemermann, J R VaneLancet (London, England)|January 1, 1977
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregationS Moncada, E A Higgs, J R VaneProstaglandins|March 1, 1977
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsJ E Tateson, S Moncada, J R VanePageof 60